In re Omeprazole Patent Litigation

Claims may be nonobvious despite an argument to combine prior art elements—as with a drug formulation using enteric coatings—where the prior art does not supply an adequate reason or expectation of success for the combination.

Generated summary for orientation only — not legal advice · medium confidence. Verify against the opinion.